Navigation Links
Stem Cells Endless Hope in Place of What Could Have Been a Hopeless End

If a leg is to be amputated with no recourse, injected stem cells could assist in reviving circulation in the affected leg. Thus stem cells offer immense hope to scientists, when the situation has turned hopeless for the patient.

Now, scientists have explored the potential of stem cells to cure a sick heart. As per recent experiments on animals, it came to light, that special class of stem cells from human embryos, called hemangioblast cells are capable of repairing blood vessels.

Enthused by this finding, American scientists have begun preparing to test the efficacy of stem cells to treat diabetics, heart attack victims and other ailments which would need new blood vessels to rectify the ailing body.

Further, stem cells can also be employed to train the immune system to accept the laboratory-grown cells used for repair. This will eventually help in phasing out the contentious cloning methods.

Dr Robert Lanza, a senior author, said, Stem cells show an amazing ability to repair vascular damage in animals.

Vice-president of research and scientific development at Advanced Cell Technology, said, We also have studies under way indicating that the cells can also considerably accelerate wound healing and repair lung damage. We might also be able to use them to treat strokes and complications of diabetes."


'"/>




Page: 1

Related medicine news :

1. Blood Cells Capable of Regenerating Liver
2. White Cells Count Can Predict Heart Attack Death Risk
3. Gene Therapy Destroys Pancreatic Cancer Cells
4. Stem Cells Have Few Mutations
5. Heart may pull Cells from Body to Self-repair
6. Cells critical for asthma development found
7. Vitamin D Wipes out Cancer Cells
8. Bone Marrow Cells Help Heart Attack Patients
9. Islet Cells May Lead to Diabetes CureChildren
10. Stem Cells Found To Offer Promise For Hair Growth
11. Bone Marrow Cells Could Yield A New Lease of Life

Post Your Comments:
(Date:11/24/2009)...ewswire/--TheBaylorCharlesA.SammonsCancerCenterhas...ialscooperativegroupsintheUnitedStates.Fundedbyres...tOncologyGroupconductsclinicaltrialstopreventandtr...ancersurvivors. ,, "Joiningthisprestigiousgroup...lstocancerpatientsinNorthTexas,"saidAlanM.Miller,M...
(Date:11/24/2009)...orkStateFraternalOrderofPolicedistributedturkeys,c...York ,, PORTJERVIS,N.Y.,Nov.24/PRNewswire-USNew...npartnershipwiththeNewYorkStateFraternalOrderofPol...lsNewYork,sChildDevelopmentCenter,ProjectDiscovery...achtoreceivefreeturkeys,ham,chickenandothertrimmin...
(Date:11/24/2009)...wire-USNewswire/--GovernorEdwardG.Rendelltodayanno...werevaccinatedduringtheweekendatpublichealthclinic...nts. ,, "Withthefederalgovernmentunabletoprovid...bilityofH1N1vaccine,distributionhasbeenchallenging...H1N1vaccinedistributionprocessinPennsylvania.Holdi...
(Date:11/24/2009)...re-USNewswire/--Dr.NelsonEscobar,aphysicianwiththe...eJamesBradyAward.TheawardwaspresentedtohimbytheBra...lconferenceonOctober30,2009. ,, AccordingtotheB...onofhisexpertiseinaddressingthecomplexneedsofperso...ceptionalcareofhispatientsandtheirfamiliesastheyre...
(Date:11/24/2009)...ard off peripheral artery disease, researchers sa...-- Among people aged 75 and older, the herbal supp...s, stroke or death, a new study finds. , There ...ght help prevent the leg-circulation problem known...o contains nutrients called flavonoids, which are ...
Breaking Medicine News(10 mins):Health News:Baylor Sammons Cancer Center Joins One of Nation's Largest Cancer Clinical Trials Groups 2Health News:Fraternal Order of Police Provides Food and Hope for Families in Port Jervis this Thanksgiving 2Health News:Governor Rendell Announces 100,000 At-Risk Pennsylvanians Vaccinated at H1N1 Public Health Clinics; Addresses Future Vaccine Distribution Plans 2Health News:Marianjoy Medical Group Physician Receives James Brady Award 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 2Health News:Ginkgo Won't Prevent Heart Attack, Stroke in Elderly 3
...ect in reversing the ultimate problem of gastroeso...ds//. A recent study by Gerson at the Stanford...ple suffering from heartburn can eat chocolate, fr...ents walk into her clinic upset, having been advis...
...earch, which revealed that there was no link betwe...t in British nuclear tests in Australia in the 195...ing to the he Federal Government commissioned stud...er Veterans Affairs Minister, Bruce Billson, said ...
...rted among Intravenous drug users (IDUs). Accordi... control and prevention (CDC) and South Africa Med...sharing and using the same needle up to 15 times e...cy Plan for AIDS Relief Meeting which was held at ...
...'s booming healthcare market, infrastructure inves... placement of Rs 90 crore in Bangalore-based Manip...in the firm. The investment was made by IDFC ...iod of five years. We will also have an option to ...
...e the passengers to risk of contacting disease lik...ited Nations //health agency has issued fresh guid...with multi-drug resistant tuberculosis must postpo...e on a commercial aircraft, where the quality of a...
...has been receiving incessant calls from four group...were infected with HIV and hepatitis C after recei...Government bill that deals with the long standing ...dress the difficulties in insurance experienced by...
Other Medicine News:Health News:No More Dietary Restriction for Heartburn Patients - Study Says 2Health News:No More Dietary Restriction for Heartburn Patients - Study Says 3Health News:No More Dietary Restriction for Heartburn Patients - Study Says 4
(Date:11/24/2009)...J.andNEWYORK,Nov.24/PRNewswire/-- EisaiInc.andPfi...ration(FDA)hasacceptedforreviewEisai,sNewDrugAppli...HClextendedrelease)tabletsforthetreatmentofmoderat...ormulationcontains23mgofdonepezilHClinanextendedre...wsforgradualreleaseofthedrug.TheNDAisbasedonahead-...
(Date:11/24/2009)...ov.24/PRNewswire/--ZargisMedicalCorp.,asubsidiaryo...sCorporateResearch(NYSE: SI ),todayannouncedthatit...2009episodeofCBS, TheEarlyShow duringasegmentinwhi...eviewedfivewinningproductsfromthepublication,s2009...dely-viewedtelevisionmorningnewstalkshowbroadcastb...
(Date:11/24/2009)...PRNewswire/--AmbitBiosciencesCorporationannouncedt...AC220,anovelsecondgenerationFLT3inhibitor,inAMLatt...)tobeheldinNewOrleans,LA,December5-8,2009.Anoralpr...lPhaseImonotherapysafetystudyinadultswithacutemyel...bepresentedevaluatingtheeffectofAC220monotherapyan...
Breaking Medicine Technology:FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 2FDA Accepts Once Daily 23 mg Aricept(R) Extended Release NDA for Review 3Zargis Cardioscan(TM) Featured on The Early Show on CBS 2Zargis Cardioscan(TM) Featured on The Early Show on CBS 3Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 2Ambit Biosciences Corporation Announces Presentations Profiling AC220 Clinical and Non-Clinical Data at 51st American Society of Hematology Annual Meeting 3Facet Solutions Enrolls 100th Patient in US Pivotal IDE Study 6113 1Facet Solutions Enrolls 100th Patient in US Pivotal IDE Study 6113 2Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 1Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 2Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 3Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 4Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 5Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 6Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 7Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 8Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 9Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 10Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 11Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 12Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 13Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 14Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 15Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 16Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 17Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 18Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 19Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 20Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 21Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 22Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 23Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 24Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 25Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 26Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 27Hologic Announces Fourth Quarter and Fiscal 2009 Operating Results 6111 28Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 1Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 2Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 3Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 4Boston Scientifics Urology Gynecology Products Featured in Studies at Global Congress 6109 5
... Additional Data Demonstrated Higher Overall Maint...mptom Relief versus Placebo --, SAN DIEGO, May 18...results from three pivotal Phase 3 studies evaluat...proton pump inhibitor (PPI),with an innovative dua...with erosive esophagitis (EE) and in maintenance o...
...NTVALE, N.J., May 16 Memory Pharmaceuticals,Corp....veral key development,programs at its R&D Day meet...orted new clinical data for MEM 1414, its lead PDE...ity in humans. In addition, the,Company has nomina...om its,5-HT6 antagonist program, and separately co...
Other Medicine Technology:TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis 2TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis 3TAP Pharmaceutical Products Inc. Announces Phase 3 TAK-390MR Data Demonstrating Higher Overall Healing Versus Lansoprazole in Patients with Erosive Esophagitis 4Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 2Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 3Memory Pharmaceuticals Highlights Progress with Key Programs at its R&D Day 4
...al reference laboratory and a worldwide leader in ...UP offers an extensive test menu of highly complex... pathology. Owned by the University of Utah, ARUP ...e nation's university teaching hospitals and child...
...n advanced scientific formulation that provides po...ct Plus is based on the AREDS clinical trial, and ...g the role of lutein in eye health. Featuring low ...nt blend of antioxidant nutrients and delivers 15 ...
...is a scientifically advanced nutritional formulati...nd full body health. MacularProtect Complete is ba... research. It features a comprehensive multinutrie...ntioxidants, such as 10 mg of FloraGLO® lutein...
Oculair
Medicine Products: